IO Biotech, Inc. (IOBTQ) Change in Account Payables (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Change in Account Payables data on file, last reported at $50000.0 in Q3 2025.

• Quarterly Change in Account Payables fell 79.08% year-over-year to $50000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $331000.0 (up 123.83% YoY) and the FY2024 annual result came in at $782000.0, up 720.63% from the prior year.
• Change in Account Payables fell to $50000.0 in Q3 2025, from $339000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.5 million in Q2 2022 to a low of -$2.8 million in Q4 2023.
• A 5-year average of $266631.6 and a median of $339000.0 in 2025 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables tumbled 604.68% — and 2025, when it jumped 1515.79%.
• Tracing IOBTQ's Change in Account Payables over 5 years: stood at $1.8 million in 2021, then gained by 4.2% to $1.8 million in 2022, then plunged by 250.71% to -$2.8 million in 2023, then jumped by 78.46% to -$596000.0 in 2024, then surged by 108.39% to $50000.0 in 2025.
• The last three Change in Account Payables figures came in at $50000.0 (Q3 2025), $339000.0 (Q2 2025), and $538000.0 (Q1 2025), per Business Quant data.